Infectious Disease Diagnostics Market Forecast to Grow at 8.20% CAGR from 2024 to 2031 | SkyQuest Technology

Global Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).
Global Infectious Disease Diagnostics [https://www.skyquestt.com/report/infectious-disease-diagnostics-market] Market size was valued at USD 21.20 billion in 2022 and is poised to grow from USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).

Increasing incidence of infectious diseases, shift of emphasis from centralized laboratories to center of care, increasing R&D activity in infectious disease diagnostics are other factors leading to market expansion. Point-of-care diagnosis provides rapid and useful information for patient care at the point of diagnosis. Consequently, many companies have focused R&D programs to develop point-of-care diagnostic solutions for developing countries. Leading companies are constantly innovating their products through the introduction of new products, joint ventures with third parties, mergers and acquisitions, all of which will contribute to the expansion of the global market.

The infectious diseases diagnostics market is growing rapidly due to increasing prevalence of infectious diseases, increasing sophistication of diagnostic tools and advancements in molecular diagnostics. The competitive scenario of this market can be classified based on players, their strategies, technological developments and collaboration.

Get a Free Sample Research Report:

https://www.skyquestt.com/sample-request/infectious-disease-diagnostics-market

Infectious Disease Diagnostics Market Segmental Analysis

Global Infectious Disease Diagnostics Market is segmented by Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User, and region.

Based on Product & Service, the market is segmented into Reagents, Kits, And Consumables, Instruments, Software & Services.

Based on Type of Testing, the market is segmented into Laboratory Testing, POC Testing. Based on Sample Type, the market is segmented into Blood, Serum, and Plasma, Urine, and Other Sample Types.

Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, Other Infectious Diseases.

Based on Technology, the market is segmented into Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Other Technologies.

Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Diagnostics at the Forefront Navigating the Competitive Landscape of Infectious Disease Detection

Large, established companies dominate market for the infectious disease testing, leveraging their global reach, advanced R&D capabilities, and portfolios. Companies such as Roche Diagnostics, Abbott Laboratories, bioMerieux, Becton Dickinson (BD) leads the market with a focus on the delivering innovative diagnostic solutions Invests heavily in technology integration and development.

Roche Diagnostics is distinguished by a strong portfolio of molecular diagnostics, particularly real-time PCR systems that are a key component in the detection of infectious disease. The company's COBAS diagnostic system plays a critical role in its market dominance.

Abbott Laboratories is focused on point-of-care testing, offering rapid diagnostic solutions such as ID NOW Trademark which is widely used to rapidly identify viruses such as SARS-CoV-2.

This report covers the following players:

* F. Hoffmann-La Roche Ltd. (Switzerland)
* Abbott (US)
* bioMerieux (France)
* Siemens Healthineers AG (Germany)
* Danaher (US)
* Thermo Fisher Scientific Inc. (US)
* Hologic, Inc. (US)
* Becton, Dickinson and Company (US)
* Revvity (US)
* Qiagen (Netherlands)
* Seegene Inc. (South Korea)
* QuidelOrtho Corporation (US)
* Grifols, S.A. (Spain)
* DiaSorin S.p.A. (Italy)
* Bio-Rad Laboratories, Inc. (US)
* Sysmex Corporation (Japan)
* OraSure Technologies (US)
* Co-Diagnostics, Inc. (US)
* Trinity Biotech (Ireland)
* Genetic Signatures Ltd. (Australia)
* Epitope Diagnostics, Inc. (US)
* Trivitron Healthcare (India)
* ELITech Group (France)
* Meril Life Sciences Pvt. Ltd. (India)
* InBios International, Inc. (US)
* Uniogen Oy (Finland)
* Vela Diagnostics (Singapore)

Ask for Customization:

https://www.skyquestt.com/speak-with-analyst/infectious-disease-diagnostics-market

Strategic Cooperation and Partnership

In May 2022, The U.S. Food and Drug Administration (FDA) has granted Abbott emergency use authorization (EUA) for the fastest available molecular point-of-care test for the detection of new coronavirus (COVID-19), which provides positive findings in as little as five minutes and negative results in 13 minutes.

In May 2022, Quidel Corporation a US-based organization that provides rapid diagnostic testing solutions, cellular-based totally virology assays, and molecular diagnostic systems, has received Ortho Clinical Diagnostics and the succeeding enterprise corporations.

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/infectious-disease-diagnostics-market

This report covers the following segments:

A. Product & Service

* Software & Services
* Instruments

B. Type of Testing

* Laboratory Testing
* POC Testing

C. Sample Type

* Blood
* Serum
* Plasma
* Urine

C. Disease Type

* Hepatitis
* Mosquito-borne Diseases

Empowering Global Health of Infectious Disease Diagnostics Market

The infectious disease diagnostics market is poised for strong growth, driven by the rising incidence of infectious diseases across the globe, including emerging pathogens such as COVID-19 and drug resistance. Companies are responding with innovations in molecular testing, point-of-care testing and rapid diagnostic tools to meet the growing demand for accurate, rapid discovery. The future of this market depends on the next technologies such as AI-enhanced diagnostic platforms, CRISPR-based detection tools, and advanced molecular diagnostic techniques.

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=infectious-disease-diagnostics-market-forecast-to-grow-at-820-cagr-from-2024-to-2031-skyquest-technology]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/infectious-disease-diagnostics-market



This release was published on openPR.